CEO Rick Stewart stated that "Achieve is on track to submit the NDA for cytisinicline next month." He emphasized that "all internal resources are now focused on a successful NDA submission, acceptance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback